Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M268Revenue $M1.7Net Margin (%)0Z-Score0
Enterprise Value $M224EPS $-1.2Operating Margin %0F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M28.2ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with BMTI

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BMTIGeorge Soros 2007-03-31 Sold Out -0.37%$12.4 - $18.34
($15.1)
$ 9.53-37%Sold Out0
BMTIGeorge Soros 2006-06-30 Buy 0.41%$6.26 - $8.13
($7.5)
$ 9.5327%New holding, 411199 sh.411,199
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BMTI is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


BMTI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pagano Russell P.VP, Reg. & Clinical Affairs 2013-01-22Sell1,381$8.1-100 view
Friedlaender Gary EDirector 2012-04-02Buy10,000$2.79-100 view
Lynch Samuel EugenePresident and CEO 2012-03-30Buy70,000$2.41-100 view
Pagano Russell P.VP, Reg. & Clinical Affairs 2012-03-29Sell3,438$2.36-100 view
Douglas Earl MartinGeneral Counsel 2012-03-28Sell53,561$2.35-100 view
PAPASAN LARRY WDirector 2012-03-27Buy10,400$2.32-100 view
Lynch Samuel EugenePresident and CEO 2012-03-23Buy13,150$2.35-100 view
BULLOCK LAWRENCE ECFO 2012-03-20Buy20,000$2.2-100 view
Friedlaender Gary EDirector 2012-03-19Buy15,000$2.19-100 view
Douglas Earl MartinGeneral Counsel 2011-10-14Sell9,000$3.01-100 view

Press Releases about BMTI :

    Quarterly/Annual Reports about BMTI:

      News about BMTI:

      Articles On GuruFocus.com
      BioMimetic Therapeutics Up $24.28% on July 10 Jul 10 2012 
      Weekly CEO Buys Highlight: VRA, MTDR, BMTI, PZG, CAK Apr 10 2012 
      Insider purchases Apr 06 2012 
      Weekly CFO Buys Highlight: SSP, BMTI, POL, ANAC, CYTX Mar 26 2012 
      BioMimetic Therapeutics Inc. Reports Operating Results (10-K) Mar 10 2011 
      BioMimetic Therapeutics Inc. Reports Operating Results (10-Q) Nov 03 2010 
      BioMimetic Therapeutics Inc. Reports Operating Results (10-Q) Aug 05 2010 
      BioMimetic Therapeutics Inc. (BMTI) President and CEO Samuel Eugene Lynch sells 6,000 Shares Dec 30 2009 
      BioMimetic Therapeutics Inc. (BMTI) President and CEO Samuel Eugene Lynch sells 6,000 Shares Dec 16 2009 
      BioMimetic Therapeutics Inc. (BMTI) President and CEO Samuel Eugene Lynch sells 6,000 Shares Dec 04 2009 

      More From Other Websites
      No related articles found.

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK